Newest first. 5.2k questions across 107 tags.
What I am working with: 95.2% · batch certificate. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Setup, so nobody has to ask: aggregation · cagrilintide · 25 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…
What I am working with: 99.1% · Medutest · 95.2% · Medutest. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can…
Stated plainly: dulaglutide · SUSTAIN-6. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…
The clinician who ordered the panel was not concerned; I would still like to understand it. The units are where I keep going wrong, so please be explicit about them.…
What I am working with: retatrutide · minus 20 °C. This has the shape of a fact but I cannot find its origin. What I found instead were three secondary sources all…
What I am working with: SUSTAIN-6 · reflux. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…
Setup, so nobody has to ask: Ireland · fourteen days. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not…
Stated plainly: 20 mg · mazdutide. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it seems…
Setup, so nobody has to ask: SUSTAIN-6 · vomiting. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Setup, so nobody has to ask: SURMOUNT-OSA · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
Details up front: SELECT · orforglipron. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
Numbers first: KP · ERP · Japan. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason than a…
Details up front: a GLP-1 receptor agonist · six weeks · 25 °C. This is a planning question. I know what my options are; I do not know how to weigh them. What I want…
Details up front: 98.4% · Janoshik · 98.2% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
What I have: a GLP-1 receptor agonist · SELECT. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Details up front: mazdutide · lot-specific certificate. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at…
What I have: cagrilintide · Xianning. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Conditions: semaglutide · Xi’an. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan to…
Conditions: 98.4% · VendorInvestigate · 97.6%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident…
Conditions: survodutide · four weeks · 40 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
Conditions: survodutide · SURPASS-3. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
I have the plan documents and the written criteria, which took two calls to obtain. I want a method I can write down and repeat, not a rule of thumb. I would rather…
The particulars: SSA · semaglutide. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I understood…